Reshaping the Future of Lung Cancer Treatment With TROP2-Targeting ADCs and Rational Combinations

Chair, Stephen V. Liu, MD, Sun Min Lim, MD, PhD, and Delvys Rodríguez Abreu, MD, PhD, discuss NSCLC in this CME activity titled “A Bold Frontier: Shattering the Limits of Conventional Therapies and Reshaping the Future of Lung Cancer Treatment With TROP2-Targeting ADCs and Rational Combinations.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFX865. CME credit will be available until October 8, 2024.